National Database of Bone Metastases
BDMO
Banca Dati Nazionale Metastasi Ossee
1 other identifier
observational
800
1 country
30
Brief Summary
BDMO is an Italian multicentre, observational, prospective study that collects data from all patients with bone metastases referred to each participating centre, using an on-line software 'tailor-made' for data collection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2013
Longer than P75 for all trials
30 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 8, 2013
CompletedFirst Submitted
Initial submission to the registry
March 13, 2024
CompletedFirst Posted
Study publicly available on registry
April 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2030
April 16, 2024
April 1, 2024
16.2 years
March 13, 2024
April 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The establishment of a National Bone Metastasis Database at the IRCCS IRST
Up to 15 years
Secondary Outcomes (6)
Evaluation of clinical factors related to the primary tumor and metastases
Up to 15 years
Evaluation of clinical factors related to the primary tumor and metastases
Up to 15 years
Evaluation of clinical factors related to the primary tumor and metastases
Up to 15 years
Impact of treatment on skeletal events (SRE)
Up to 15 years
Analysis of overall efficiency of the mono- and multidisciplinary pathway on skeletal events (SRE)
Up to 15 years
- +1 more secondary outcomes
Study Arms (1)
Patients with bone metastasis
All patients with bone metastasis
Interventions
All patients with bone metastasis enrolled at the centre will be entered into the database and followed until death or interruption of follow-up for any another cause
Eligibility Criteria
Patients with bone metasis in any site.
You may qualify if:
- Radiological and/or histological diagnosis of bone metastasis from histologically established solid tumor
- Males or females aged \>= 18 years
- Informed consent
You may not qualify if:
- Not applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (30)
A.U.S.L. Imola
Imola, Bologna, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)
Meldola, FC, 47014, Italy
Osp. "Sacro Cuore di Gesù"
Gallipoli, Lecce, Italy
Osp. S. Vincenzo - ASP Messina
Taormina, Messina, Italy
Osp. Ramazzini di Carpi - AUSL Modena
Carpi, Modena, Italy
P.O. "S. Maria delle Grazie"
Pozzuoli, Napoli, Italy
Osp. degli Infermi
Faenza, Ravenna, Italy
Ospedale Umberto I
Lugo, Ravenna, Italy
Istituto Neurotraumatologico Italiano (INI)
Grottaferrata, Roma, Italy
A.O.U. Ospedali Riuniti
Ancona, Italy
Centro di Riferimento Oncologico - IRCCS CRO
Aviano, Italy
A.O.U.C. Policlinico di Bari Osp."Giovanni XXIII"
Bari, Italy
A.O. "S. Pio"
Benevento, Italy
IRCCS Ist. Ortopedico Rizzoli
Bologna, Italy
ASST Spedali Civili di Brescia
Brescia, Italy
A.O. S. Croce e Carle
Cuneo, Italy
A.O.U. "Arcispedale S. Anna" - AUSL Ferrara
Ferrara, Italy
Ospedale Civile di Legnano - ASST Ovest Milanese
Legnano, Italy
Fond. IRCCS Istituto Nazionale dei Tumori - INT
Milan, Italy
A.O.R.N. "A. Cardarelli"
Napoli, Italy
Istituto Oncologico Veneto
Padua, Italy
Fond. IRCCS Policlinico San Matteo
Pavia, Italy
Osp. Guglielmo da Saliceto
Piacenza, Italy
Osp. S. Maria delle Croci
Ravenna, Italy
IRCCS Arcispedale S. Maria Nuova - A.O. Reggio Emilia
Reggio Emilia, Italy
Ospedale degli Infermi
Rimini, Italy
IRCCS Fond. Policlinico "A. Gemelli" - U.O.C. Oncologia Medica
Roma, Italy
IRCCS Fond. Policlinico "A. Gemelli" - U.O.S. Senologia Medica / U.O.C. Ginecologia oncologica
Roma, Italy
Ospedale di Treviglio - Caravaggio ASST Bergamo Ovest
Treviglio, Italy
A.O.U.I. Verona
Verona, Italy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 20 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2024
First Posted
April 16, 2024
Study Start
October 8, 2013
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
January 1, 2030
Last Updated
April 16, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share